https://www.shinfield-pharma.com/european-commission-grants-orphan-drug-designation-to-soliris-eculizumab-for-the-treatment-of-patients-with-myasthenia-gravis-mg/2014-08-30T13:56:16+00:00https://www.shinfield-pharma.com/european-medicines-agency-accepts-marketing-authorization-application-for-asfotase-alfa-as-a-treatment-for-patients-with-hypophosphatasia/2014-08-30T13:56:06+00:00https://www.shinfield-pharma.com/fda-approves-conversion-of-soliris-eculizumab-accelerated-approval-in-ahus-to-regular-approval-for-the-treatment-of-patients-with-ahus/2014-08-30T13:39:30+00:00https://www.shinfield-pharma.com/breaking-world-pharma-news/2014-11-20T15:13:36+00:00https://www.shinfield-pharma.com/fda-warns-consumers-about-fraudulent-ebola-treatment-products/2014-11-20T15:03:54+00:00https://www.shinfield-pharma.com/article-england-could-lose-16000-gps/2014-11-20T15:15:04+00:00